225 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
GWPH GW Pharmaceuticals Plc $108.375 $2.74B N/A
Article Searches
Stocks making the biggest moves premarket: VIAB, TRCO, BKNG, PRTY & more https://www.cnbc.com/2018/08/09/stocks-making-the-biggest-moves-premarket-viab-trco-bkng-prty--mo.html Aug 09, 2018 - Names on the move ahead of the open.
Avoid Extreme Stocks - Cramer's Mad Money (7/24/18) https://seekingalpha.com/article/4189794-avoid-extreme-stocks-cramers-mad-money-7-24-18?source=feed_tag_cramers_picks Jul 25, 2018 - The S&P 500 could make all-time highs by the end of earnings season.Danaher has more room to run.Dominion Midstream Partners has become too cheap.
Scotts Miracle-Gro Deserves To Be Lower - Cramer's Lightning Round (7/24/18) https://seekingalpha.com/article/4189780-scotts-miracle-gro-deserves-lower-cramers-lightning-round-7-24-18?source=feed_tag_cramers_picks Jul 25, 2018 - World Wrestling Entertainment is still worth buying.Coca-Cola's growth is slow and steady.BP plc is a better pick than Royal Dutch Shell.
CarMax, J.M. Smucker, Innovative Industrial Properties and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day http://www.zacks.com/stock/news/312641/carmax-jm-smucker-innovative-industrial-properties-and-gw-pharmaceuticals-highlighted-as-zacks-bull-and-bear-of-the-day?cid=CS-ZC-FT-312641 Jul 23, 2018 - CarMax, J.M. Smucker, Innovative Industrial Properties and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day
Stocks To Watch: FANGs Out In Tech https://seekingalpha.com/article/4188911-stocks-watch-fangs-tech?source=feed Jul 21, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Rounds Report: AVEO Rallied As Investors Are Optimistic About TIVO-3 Future Development https://seekingalpha.com/article/4188630-rounds-report-aveo-rallied-investors-optimistic-tivominus-3-future-development?source=feed_sector_healthcare Jul 20, 2018 - The overall bioscience market traded northbound due to the resurgence of investors' confidence. Many firms under our coverage enjoyed further gains.Aveo Pharmaceuticals topped our featured list due to
Will Marijuana Stocks Bloom as US Moves Toward Legalization? http://www.zacks.com/stock/news/312427/will-marijuana-stocks-bloom-as-us-moves-toward-legalization?cid=CS-ZC-FT-312427 Jul 20, 2018 - Legalization of recreational marijuana is on the verge of becoming a reality in the United States
IOMachine Runthroughs: Buy GW Pharma On Current Approval And Future Catalysts https://seekingalpha.com/article/4187729-iomachine-runthroughs-buy-gw-pharma-current-approval-future-catalysts?source=feed_sector_healthcare Jul 17, 2018 - This is part of a series of IOMachine runthroughs, explained below.GWPH still has considerable upside.A number of catalysts are due in the next few months.
Biotech Analysis Central Pharma News: Zogenix's Late-Stage Win, Zynerba's Bounce Back, Abbvie's Expanded Venetoclax Use https://seekingalpha.com/article/4187381-biotech-analysis-central-pharma-news-zogenixs-late-stage-win-zynerbas-bounce-back-abbvies?source=feed_sector_healthcare Jul 16, 2018 - Zogenix announces positive phase 3 results for Dravet Syndrome.Zynerba Pharmaceuticals cuts ZYN001 program after phase 1 trial disappoints.Abbvie submits sNDA to FDA for expanded use of venetoclax.
GW Pharmaceuticals: What The Recent Epidiolex Approval Foretells https://seekingalpha.com/article/4187040-gw-pharmaceuticals-recent-epidiolex-approval-foretells?source=feed_sector_healthcare Jul 13, 2018 - GW Pharmaceuticals is powering a highly robust and extensive pipeline of promising novel molecules.Sativex is being commercialized in the EU for the treatment of spasticity associated with multiple sc

Pages: 123456...23

Page 1>

Related Companies

Name Exchange Price Mkt Cap
AXON Axovant Sciences Ltd. NASDAQ $25 $2.69B
LGND Ligand Pharmaceuticals Incorporated NASDAQ $135.56 $2.85B
PBH Prestige Brand Holdings, Inc. NYSE $49.11 $2.6B
LOXO Loxo Oncology, Inc. NASDAQ $86.82 $2.59B
MDCO The Medicines Company NASDAQ $35.44 $2.57B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for GW Pharmaceuticals Plc